Real-time enrollment status for this supratentorial hemorrhage clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:37 AM UTC
| NCT Number | NCT04494295 |
| Recruiting Status | Recruiting |
| Condition | Supratentorial Hemorrhage |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Integra LifeSciences Corporation |
| Last Updated on CT.gov | February 6, 2026 (Feb 6, 2026) |
As of July 13, 2026: Clinical trial NCT04494295 is currently recruiting participants. This clinical trial study for supratentorial hemorrhage is actively seeking new participants at 20 locations across the United States. The study is sponsored by Integra LifeSciences Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04494295 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04494295 was last updated Feb 6, 2026 (February 6, 2026). HelloStudys verifies this status automatically.